Not only ESBL-producing E. coli strains cause therapeutic problems. A case report;Nicht nur ESBL produzierende E.-coli-Stamme bereiten therapeutische probleme - Ein fallbericht

Chemotherapie Journal

Volumn 9, Issue 4, 2000, Pages 153-154

  Westphal, K ^a   Wiegand, I ^a   Pfeil, E ^a   Krupe, H ^a   Kremer, M ^a   Wiedemann, B ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; GENTAMICIN; IMIPENEM; PIPERACILLIN; SULBACTAM; TAZOBACTAM;

ADOLESCENT; ARTICLE; ASPIRATION PNEUMONIA; CASE REPORT; ENZYME SPECIFICITY; ESCHERICHIA COLI; HUMAN; MINIMUM INHIBITORY CONCENTRATION; POSTOPERATIVE INFECTION; SEPSIS;

EID: 0033875220     PISSN: 09406735     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Molecular characterisation by PCR-restriction fragment length polymorphism of TEM β-lactamases
2. Is it important to identify extended-spectrum beta-lactamase-producing isolates?
3. A functional classification scheme for β-lactamases and its correlation with molecular structure
4. Genetics of extended-spectrum beta-lactamases
5. Pravalenz der antibiotikaresistenz bei klinisch wichtigen infektioaserregern in mitteleuropa. Bericht uber die ergebnisse einer multizentrischen studie der arbeitsgemeinschaft 'resistenz' in der Paul-Ehrlich-Gesellschaft fur chemotherapie e. V. aus dem jahre 1998
6. β-Lactamases in laboratory and clinical resistance
7. Activity of sulbactam combinations against Escherichia coli isolates with known amounts of TEM-1 β-lactamase
8. Recent increase in resistance of β-lactamases: Mechanisms and organisms evolution and dissemination of β-lactamases accelerated by generation of β-lactam antibiotics
9. Can results obtained with commerqially available MicroScan microdilution panels serve as an indicator of β-lactamase production among Escherichia coli and Klebsiella isolates with hidden resistance to expanded-spectrum cephalosporins and aztreonam?
10. Novel method for detection of β-lactamases using chromogenic cephalosporin substrate
11. Activity of clavulanate combinations against TEM-1 β-lactamase-producing Escherichia coli isolates obtained in 1982 and 1989